• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AIZU OLYMPUS CO., LTD. EVIS DUODENOVIDEOSCOPE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AIZU OLYMPUS CO., LTD. EVIS DUODENOVIDEOSCOPE Back to Search Results
Model Number JF-240
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Pancreatitis (4481)
Event Date 04/17/2023
Event Type  Injury  
Event Description
Olympus medical systems corp.(omsc) received a literature titled "guide wire selection (straight vs angled) in endoscopic retrograde cholangiopancreatography using a normal contrast catheter performed by a trainee: a single-center prospective randomized controlled cross-over study".Literature summary: introduction: wire-guided cannulation (wgc) during endoscopic retrograde cholangiopancreatography (ercp) is a selective biliary cannulation technique aimed at improving the successful selective biliary cannulation rate and reducing the rate of post-ercp pancreatitis (pep) incidence.This study aimed to evaluate the effectiveness of angled-tip guidewires (agw) vs.Straight-tip guidewires (sgw) for biliary cannulation via wgc by a trainee.Methods: we conducted a prospective, single-center, open-labeled, randomized, and controlled trial.Fifty-seven patients were enrolled in this study and assigned randomly to two groups (group a to s and group s to a).In this study, we started selective biliary cannulation via wgc with an agw or an sgw for 7 min.If cannulation was unsuccessful, the other guidewire was used, and cannulation was continued for another 7 min (cross-over method).Results: the selective biliary cannulation success rate over 14 min was significantly higher with an agw compared with an sgw over 14 min (57.8% vs.34.3%, p = 0.04) and for the second 7-min segment (36.4% vs.0%, p = 0.04).No significant difference was found for adverse events such as pancreatitis between the two guidewires.Conclusions: our results suggest that an agw is recommended for wgc performed by a trainee.Type of adverse events/number of patients: pancreatitis (4).The report is linked to the related patient identifier (b)(6).
 
Manufacturer Narrative
Once the investigation has been completed, a supplemental report will be submitted with device evaluation results.
 
Manufacturer Narrative
This report is being supplemented to provide additional information based on the legal manufacturer's final investigation.The device history record was unable to be reviewed for this device since the serial and/or lot number was not provided.However, olympus only releases products to market that meet all manufacturing specifications and final product release criteria.Based on the results of the investigation, a relationship between the device and the adverse event cannot be confirmed.There was no complaint reported on the subject device.There is no evidence of an olympus device malfunction.Therefore, the root cause cannot be determined.Olympus will continue to monitor field performance for this device.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EVIS DUODENOVIDEOSCOPE
Type of Device
DUODENOVIDEOSCOPE
Manufacturer (Section D)
AIZU OLYMPUS CO., LTD.
3-1-1 niiderakita
aizuwakamatsu-shi, fukushima 965-8 520
JA  965-8520
Manufacturer (Section G)
AIZU OLYMPUS CO., LTD.
3-1-1 niiderakita
aizuwakamatsu-shi, fukushima
Manufacturer Contact
todd brill
800 west park drive
westborough, MA 01581
5082077661
MDR Report Key18664150
MDR Text Key334833280
Report Number9610595-2024-02686
Device Sequence Number1
Product Code FDT
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
K954451
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Study,Literature,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 04/15/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/07/2024
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberJF-240
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Date Manufacturer Received04/15/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
Treatment
ANGLED-TIP OR STRAIGHT-TIP (VISIGLIDE 2); JF-240, DUODENOSCOPE; NON-OLYMPUS, DOUBLE-LUMEN INJECTION CATHETER; TJF260V, DUODENOSCOPE
Patient Outcome(s) Other;
-
-